# Boston Scientific Acquires Penumbra for $14.5B to Enter Thrombectomy Market

> ma · REPORTED · 2026-01-15

Boston Scientific announced in January 2026 the acquisition of Penumbra for approximately $14.5 billion, giving it a broad portfolio of clot-removal and embolization devices across pulmonary embolism, stroke, and deep vein thrombosis indications. The deal closed in the first half of 2026 and represents the largest medtech deal of 2026 to date.

About Boston Scientific: Boston Scientific is a global medtech company developing minimally invasive devices across cardiovascular, neuromodulation, urology, and endoscopy; Penumbra added a major thrombectomy and embolization device franchise targeting vascular and neurovascular disease.

- Company: Boston Scientific
- Sector: medical devices
- Primary source: https://www.medtechdive.com/news/top-10-medtech-deals-in-the-first-half-of-2026/824435/

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.